In IBD cases, the intestinal barrier is compromised, marked by the downregulation of epithelial cadherin within tight junctions, leading to decreased mucus thickness, altered goblet cell function—including mucin 2 and resistin-like molecule β (RELMβ)—, and impaired Paneth cell activity (1). This evidence concerns the gene CDH17 and inflammatory bowel disease.